Inventor · disambiguated record
Stephen E. Fawell
Also filed as: FAWELL STEPHEN E · FAWELL STEPHEN ERIC
8 granted patents·3 pending applications·1,836 citations·filing 1994–2013
93Inventor score
Top patents by PatentIndex Score
11 records- 0198US5747641ATat-derived transport polypeptide conjugatesBIOGEN INC·Filed 1995·Granted May 5, 1998·319 cites·5 claims
- 0298US5674980AFusion protein comprising tat-derived transport moietyBIOGEN INC·Filed 1995·Granted Oct 7, 1997·349 cites·10 claims
- 0397US5804604ATat-derived transport polypeptides and fusion proteinsBIOGEN INC·Filed 1995·Granted Sep 8, 1998·470 cites·14 claims
- 0497US5652122ANucleic acids encoding and methods of making tat-derived transport polypeptidesFiled 1995·Granted Jul 29, 1997·286 cites·9 claims
- 0596US5670617ANucleic acid conjugates of tat-derived transport polypeptidesBIOGEN INC·Filed 1995·Granted Sep 23, 1997·189 cites·4 claims
- 0694US6316003B1Tat-derived transport polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1994·Granted Nov 13, 2001·174 cites·11 claims
- 0792US7422899B2Antibodies to the human prolactin receptorBIOGEN IDEC INC·Filed 2006·Granted Sep 9, 2008·47 cites·13 claims
- 0872US7534424B2Method of enhancing delivery of a therapeutic nucleic acidBIOGEN IDEC INC·Filed 2003·Granted May 19, 2009·2 cites·11 claims
- 0955US2009017044A1Antibodies to the Human Prolactin ReceptorBIOGEN IDEC INC·Filed 2008·Application pending·0 cites
- 1052US2005070493A1Methods and compositions for treating Parkinson's diseaseFiled 2004·Application pending·0 cites
- 1142US2015051227A1Predictive biomarker useful for cancer therapy mediated by a cdk inhibitorMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →